CIK 0001809196 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in P7 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-27 | 4 | 4 | 2026-08-26 |
| 2026-08-27 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-08-26 | 6-K | 6-K | 2026-08-26 |
| 2026-08-25 | 424B2 | 424B2 | |
| 2026-08-18 | 4 | FORM 4 | 2026-08-14 |
| 2026-08-18 | 6-K | 6-K | 2026-06-30 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-29 | 3 | 3 | 2026-07-20 |
| 2026-06-25 | S-8 | FORM S-8 | |
| 2026-06-18 | 4 | FORM 4 | 2026-06-16 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-16 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-16 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-16 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-16 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-16 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-16 |
| 2026-06-18 | 4 | 4 | 2026-06-16 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-16 |
| 2026-06-18 | 6-K | FORM 6-K | 2026-06-18 |
| 2026-06-02 | 6-K | FORM 6-K | 2026-06-02 |
| 2026-06-01 | 6-K | FORM 6-K | 2026-06-01 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-15 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A |
Forms on file (last 1,000): 6-K 93, 3 20, SCHEDULE 13G/A 18, 4 11, SC 13G/A 11, CORRESP 9, UPLOAD 9, 424B3 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=IMTX (0.002 USD), /gw/filings/filings?ticker=IMTX&form=8-K, /gw/filings/facts?ticker=IMTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange